All News
Ozempic Shows Benefit in Type 1 Diabetes Patients With Obesity
(MedPage Today) -- CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed.
Read MoreMifepristone Helped Control Diabetes in Those With Hypercortisolism
(MedPage Today) -- CHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and hypercortisolism, a randomized placebo-controlled trial showed.
Read MoreNumber of Abortions Kept Rising in 2024 Due to Telehealth Scripts, Report Says
(MedPage Today) -- The number of abortions in the U.S.
Read MoreSTAT+: Vertex stem cell therapy spurs insulin independence
And other biotech news brought to you by The Readout.
Read MoreMuchas personas mayores aceptan las vacunas con entusiasmo. La investigación les da la razón
Para los adultos mayores que expresan mayor confianza en la seguridad de las vacunas que los grupos más jóvenes, los últimos meses han traído consigo investigaciones muy positivas.
Read MoreOpinion: The Senate’s version of Trump’s tax-cut bill threatens safety-net hospitals like ours
Senate version of Trump’s tax-cut bill “poses an existential threat to our hospitals and to the Medicaid and Medicare beneficiaries we serve,” write CEOs of two major health systems.
Read MoreHow does extreme heat affect the body and what can you do about it?
As heatwaves grip the US, placing millions under advisories, experts describe how to mitigate effects of heat stressThe US is in a record-breaking heatwave, with tens of millions people on alert.
Read MoreSTAT+: Amgen’s obesity drug led to high discontinuation rates in mid-stage trial, as company plans to adjust dosing
Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a mid-stage trial, as the company plans to adjust dosing.
Read MoreNovel GLP-1/GIP Agent Led to Weight Loss With Once-Monthly Dosing
(MedPage Today) -- CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in patients with obesity with or without type 2 diabetes, a p
Read MoreU.S. Neonatal Mortality Has Declined in Recent Years, Though Not For All Causes
(MedPage Today) -- Over the last two decades, U.S. neonatal mortality has generally declined, though this was not true for all leading causes of death, a retrospective cohort study suggested.
Read More